Table 3. BCVA improvements and central macular thickness decrease over study follow-up.

	BCVA		P1		P-value Between 2 Groups
	1	2	1	2
BCVA improvements
7 Days	−1.61 (6.87)	0.70 (6.36)	0.242	0.413	0.271
1 Month	−1.19 (10.67)	2.40 (4.64)	0.394	0.001	0.221
3 Months	0.74 (9.20)	3.50 (6.38)	0.165	0.019	0.659
6 Months	4.03 (9.02)	2.17 (7.41)	0.035	0.065	0.428
Central macular thickness decrease
7 Days	−3.42 (62.27)	−25.85 (43.13)	0.626	0.055	0.787
1 Month	−15.05 (51.58)	−14.80 (104.45)	0.158	0.465	0.664
3 Months	−49.67 (69.17)	−23.29 (89.89)	0.001	0.156	0.126
6 Months	−62.30 (102.52)	−23.63 (80.99)	0.005	0.040	0.399

Abbreviation: BCVA, best-corrected visual acuity.

Data are mean±SD.

P₁ are the P-value of data compared with baseline.